Publication | Closed Access
Preclinical safety profile of disitamab vedotin：a novel anti-HER2 antibody conjugated with MMAE
45
Citations
10
References
2019
Year
MedicineImmunologyTherapeutic EfficacyAntibody ScreeningPharmacotherapyAntibody EngineeringImmunotherapyPharmacologyPreclinical Safety Profile
| Year | Citations | |
|---|---|---|
Page 1
Page 1